30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Healthcare Equipment & Supplies

Neuropace Inc (NPCE)

Track

The most recent insider trading activity occurred on December 15, 2025, with planned and proposed sales by Martha Morrell. Prior to this, significant sales were reported by ORBIMED ADVISORS LLC and KCK LTD. in May and October 2025, respectively. The majority of recent transactions have been sales.
Stock chart
Ticker: NPCE Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Morrell Martha
CHIEF MEDICAL OFFICER
1 sale — total 399,250 USD
Planned sale 15 Dec 2025
Value US$3,253,586.41 | Price 394.95 | Shares 93,761
Proposed sale 15 Dec 2025
Value US$4,120,405.99 | Price 307.96 | Shares 32,481
Sale 14 May 2025
Value US$541,960.00 | Price 15.94 | Shares 34,000
Sale 14 May 2025
Value US$2,123,372.88 | Price 15.83 | Shares 134,136
Planned sale 21 Feb 2025
Value US$1,074,844.31 | Price 13.72 | Shares 78,334
Sale 20 Feb 2025
Value US$49,545,943.00 | Price 9.40 | Shares 5,270,845
Planned sale 30 Jan 2025
Value US$3,000.00 | Price 15.00 | Shares 200
Proposed sale 30 Jan 2025
Value US$1,153,664.46 | Price 14.69 | Shares 78,534
Planned sale 29 Jan 2025
Value US$1,500.00 | Price 15.00 | Shares 100
Proposed sale 29 Jan 2025
Value US$1,413.00 | Price 14.13 | Shares 100
Planned sale 24 Jan 2025
Value US$48,032.00 | Price 15.01 | Shares 3,200
Proposed sale 24 Jan 2025
Value US$44,864.00 | Price 14.02 | Shares 3,200
Proposed sale 25 Oct 2024
Value US$1,221,042.14 | Price 5.45 | Shares 223,991
Sale 25 Oct 2024
Value US$1,221,042.14 | Price 5.45 | Shares 223,991
Sale 23 Oct 2024
Value US$884.94 | Price 6.02 | Shares 147
Sale 22 Oct 2024
Value US$24,853.26 | Price 6.09 | Shares 4,082
Sale 21 Oct 2024
Value US$22,678.61 | Price 6.10 | Shares 3,720
Sale 18 Oct 2024
Value US$30,691.89 | Price 6.29 | Shares 4,878
Sale 17 Oct 2024
Value US$20,686.32 | Price 6.28 | Shares 3,294
Sale 16 Oct 2024
Value US$45,336.45 | Price 6.57 | Shares 6,900
Sale 15 Oct 2024
Value US$26,098.45 | Price 6.50 | Shares 4,017
Sale 14 Oct 2024
Value US$26,359.92 | Price 6.54 | Shares 4,031
Sale 11 Oct 2024
Value US$16,319.60 | Price 6.35 | Shares 2,572
Sale 10 Oct 2024
Value US$15,316.97 | Price 6.12 | Shares 2,504
Sale 9 Oct 2024
Value US$19,065.29 | Price 6.10 | Shares 3,123
Sale 8 Oct 2024
Value US$38,551.80 | Price 6.43 | Shares 6,000
Sale 7 Oct 2024
Value US$32,687.34 | Price 6.66 | Shares 4,910
Sale 4 Oct 2024
Value US$39,829.80 | Price 6.92 | Shares 5,757
Sale 3 Oct 2024
Value US$23,114.85 | Price 6.97 | Shares 3,318
Sale 2 Oct 2024
Value US$26,401.41 | Price 6.87 | Shares 3,843
Sale 1 Oct 2024
Value US$33,051.14 | Price 6.77 | Shares 4,882
Sale 30 Sep 2024
Value US$31,960.77 | Price 6.73 | Shares 4,749
Sale 27 Sep 2024
Value US$33,541.17 | Price 6.63 | Shares 5,059
Sale 26 Sep 2024
Value US$38,535.02 | Price 6.62 | Shares 5,821
Sale 25 Sep 2024
Value US$38,662.80 | Price 6.60 | Shares 5,858
Sale 23 Sep 2024
Value US$2,126.28 | Price 7.54 | Shares 282
Sale 20 Sep 2024
Value US$5,737.50 | Price 7.50 | Shares 765
Sale 13 Sep 2024
Value US$15,126.87 | Price 7.59 | Shares 1,993
Sale 6 Sep 2024
Value US$82.50 | Price 7.50 | Shares 11
Sale 4 Sep 2024
Value US$105.00 | Price 7.50 | Shares 14
Sale 3 Sep 2024
Value US$15,906.80 | Price 7.60 | Shares 2,093
Proposed sale 30 Aug 2024
Value US$1,474,400.00 | Price 7.76 | Shares 190,000
Sale 30 Aug 2024
Value US$33,476.64 | Price 7.76 | Shares 4,314
Sale 3 May 2024
Value US$65,576.22 | Price 14.03 | Shares 4,674
Sale 2 May 2024
Value US$123,876.42 | Price 14.01 | Shares 8,842
Sale 1 May 2024
Value US$219,973.80 | Price 14.02 | Shares 15,690
Sale 24 Apr 2024
Value US$25,040.86 | Price 14.06 | Shares 1,781
Sale 23 Apr 2024
Value US$311,393.39 | Price 14.29 | Shares 21,791
Sale 22 Apr 2024
Value US$345,756.45 | Price 14.05 | Shares 24,609
Sale 19 Apr 2024
Value US$255,907.06 | Price 14.02 | Shares 18,253
Sale 18 Apr 2024
Value US$36,879.38 | Price 14.06 | Shares 2,623
Sale 17 Apr 2024
Value US$4,245.00 | Price 14.15 | Shares 300
Sale 16 Apr 2024
Value US$197,106.69 | Price 14.01 | Shares 14,069
Sale 12 Apr 2024
Value US$333,116.42 | Price 14.42 | Shares 23,101
Sale 11 Apr 2024
Value US$6,692,916.51 | Price 14.49 | Shares 461,899
Proposed sale 15 Mar 2024
Value US$53,629.00 | Price 13.63 | Shares 3,936
Planned sale 5 Feb 2024
Value US$52,278.23 | Price 15.17 | Shares 3,446
Planned sale 2 Feb 2024
Value US$213,122.28 | Price 15.07 | Shares 14,143
Planned sale 1 Feb 2024
Value US$9,971.06 | Price 15.04 | Shares 663
Planned sale 31 Jan 2024
Value US$28,989.61 | Price 15.08 | Shares 1,923
Planned sale 30 Jan 2024
Value US$170,004.39 | Price 15.10 | Shares 11,262
Planned sale 25 Jan 2024
Value US$15.00 | Price 15.00 | Shares 1
Planned sale 24 Jan 2024
Value US$12,425.68 | Price 15.03 | Shares 827
Planned sale 27 Dec 2023
Value US$134,647.87 | Price 10.12 | Shares 13,300
Planned sale 26 Dec 2023
Value US$1,020.00 | Price 10.00 | Shares 102
Planned sale 20 Dec 2023
Value US$27,695.30 | Price 10.14 | Shares 2,730
Proposed sale 20 Dec 2023
Value US$483,486.00 | Price 9.99 | Shares 48,397
Planned sale 6 Dec 2023
Value US$89,773.29 | Price 8.16 | Shares 11,005
Proposed sale 6 Dec 2023
Value US$89,773.29 | Price 8.16 | Shares 11,005
Sale 1 Dec 2023
Value US$28,293.93 | Price 8.73 | Shares 3,241
Sale 30 Nov 2023
Value US$64,372.88 | Price 8.84 | Shares 7,282
Sale 29 Nov 2023
Value US$49,215.68 | Price 8.72 | Shares 5,644
Sale 28 Nov 2023
Value US$40,958.75 | Price 8.75 | Shares 4,681
Proposed sale 27 Nov 2023
Value US$2,297,186.64 | Price 8.74 | Shares 262,836
Sale 27 Nov 2023
Value US$58,150.40 | Price 8.96 | Shares 6,490
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-04 2025-12-15 PlS Planned sale
Morrell Martha

CHIEF MEDICAL OFFICER

Officer
93,761 +39.9%
394.95
US$3,253,586 		93,761 +39.9% 394.95 US$3,253,586
2025-12-15 2025-12-15 PrS Proposed sale
MARTHA J MORRELL

Officer

Officer
32,481
307.96
US$4,120,406 		32,481 307.96 US$4,120,406
2025-05-16 2025-05-14 S Sale
2.6
ORBIMED ADVISORS LLC
Large shareholder
9,718 -21.2%
405.68
US$1,388,355 		9,718 -21.2% 405.68 US$1,388,355
2025-05-16 2025-05-14 S Sale
2.6
ORBIMED ADVISORS LLC
Large shareholder
134,136 -3.9%
15.83
US$2,123,373 		134,136 -3.9% 15.83 US$2,123,373
2025-02-25 2025-02-21 PlS Planned sale
Morrell Martha

CHIEF MEDICAL OFFICER

Officer
78,334 -48.9%
13.72
US$1,074,844 		78,334 -48.9% 13.72 US$1,074,844
2025-02-20 2025-02-20 S Sale
1.5
KCK LTD.
Large shareholder
5,270,845 -100.0%
9.40
US$49,545,943 		5,270,845 -100.0% 9.40 US$49,545,943
2025-01-31 2025-01-30 PlS Planned sale
Morrell Martha

CHIEF MEDICAL OFFICER

Officer
200 -0.2%
15.00
US$3,000 		200 -0.2% 15.00 US$3,000
2025-01-30 2025-01-30 PrS Proposed sale
MARTHA J MORRELL

Officer

Officer
78,534
14.69
US$1,153,664 		78,534 14.69 US$1,153,664
2025-01-31 2025-01-29 PlS Planned sale
Morrell Martha

CHIEF MEDICAL OFFICER

Officer
100 -0.1%
15.00
US$1,500 		100 -0.1% 15.00 US$1,500
2025-01-29 2025-01-29 PrS Proposed sale
MARTHA J MORRELL

Officer

Officer
100
14.13
US$1,413 		100 14.13 US$1,413
2025-01-28 2025-01-24 PlS Planned sale
Morrell Martha

CHIEF MEDICAL OFFICER

Officer
3,200 -3.5%
15.01
US$48,032 		3,200 -3.5% 15.01 US$48,032
2025-01-24 2025-01-24 PrS Proposed sale
MARTHA J MORRELL

Officer

Officer
3,200
14.02
US$44,864 		3,200 14.02 US$44,864
2024-10-28 2024-10-25 PrS Proposed sale
1.5
KCK LTD.

10% Stockholder

Large shareholder
223,991
5.45
US$1,221,042 		223,991 5.45 US$1,221,042
2024-10-28 2024-10-25 S Sale
1.5
KCK LTD.
Large shareholder
223,991 -4.1%
5.45
US$1,221,042 		223,991 -4.1% 5.45 US$1,221,042
2024-10-28 2024-10-23 S Sale
1.5
KCK LTD.
Large shareholder
147 -0.0%
6.02
US$885 		147 -0.0% 6.02 US$885
2024-10-24 2024-10-22 S Sale
1.5
KCK LTD.
Large shareholder
4,082 -0.1%
6.09
US$24,853 		4,082 -0.1% 6.09 US$24,853
2024-10-22 2024-10-21 S Sale
1.5
KCK LTD.
Large shareholder
3,720 -0.1%
6.10
US$22,679 		3,720 -0.1% 6.10 US$22,679
2024-10-22 2024-10-18 S Sale
1.5
KCK LTD.
Large shareholder
4,878 -0.1%
6.29
US$30,692 		4,878 -0.1% 6.29 US$30,692
2024-10-18 2024-10-17 S Sale
1.5
KCK LTD.
Large shareholder
3,294 -0.1%
6.28
US$20,686 		3,294 -0.1% 6.28 US$20,686
2024-10-18 2024-10-16 S Sale
1.5
KCK LTD.
Large shareholder
6,900 -0.1%
6.57
US$45,336 		6,900 -0.1% 6.57 US$45,336
2024-10-18 2024-10-15 S Sale
1.5
KCK LTD.
Large shareholder
4,017 -0.1%
6.50
US$26,098 		4,017 -0.1% 6.50 US$26,098
2024-10-18 2024-10-14 S Sale
1.5
KCK LTD.
Large shareholder
4,031 -0.1%
6.54
US$26,360 		4,031 -0.1% 6.54 US$26,360
2024-10-18 2024-10-11 S Sale
1.5
KCK LTD.
Large shareholder
2,572 -0.0%
6.35
US$16,320 		2,572 -0.0% 6.35 US$16,320
2024-10-18 2024-10-10 S Sale
1.5
KCK LTD.
Large shareholder
2,504 -0.0%
6.12
US$15,317 		2,504 -0.0% 6.12 US$15,317
2024-10-18 2024-10-09 S Sale
1.5
KCK LTD.
Large shareholder
3,123 -0.1%
6.10
US$19,065 		3,123 -0.1% 6.10 US$19,065
2024-10-18 2024-10-08 S Sale
1.5
KCK LTD.
Large shareholder
6,000 -0.1%
6.43
US$38,552 		6,000 -0.1% 6.43 US$38,552
2024-10-18 2024-10-07 S Sale
1.5
KCK LTD.
Large shareholder
4,910 -0.1%
6.66
US$32,687 		4,910 -0.1% 6.66 US$32,687
2024-10-18 2024-10-04 S Sale
1.5
KCK LTD.
Large shareholder
5,757 -0.1%
6.92
US$39,830 		5,757 -0.1% 6.92 US$39,830
2024-10-18 2024-10-03 S Sale
1.5
KCK LTD.
Large shareholder
3,318 -0.1%
6.97
US$23,115 		3,318 -0.1% 6.97 US$23,115
2024-10-03 2024-10-02 S Sale
1.5
KCK LTD.
Large shareholder
3,843 -0.1%
6.87
US$26,401 		3,843 -0.1% 6.87 US$26,401
2024-10-03 2024-10-01 S Sale
1.5
KCK LTD.
Large shareholder
4,882 -0.1%
6.77
US$33,051 		4,882 -0.1% 6.77 US$33,051
2024-10-03 2024-09-30 S Sale
1.5
KCK LTD.
Large shareholder
4,749 -0.1%
6.73
US$31,961 		4,749 -0.1% 6.73 US$31,961
2024-10-03 2024-09-27 S Sale
1.5
KCK LTD.
Large shareholder
5,059 -0.1%
6.63
US$33,541 		5,059 -0.1% 6.63 US$33,541
2024-10-03 2024-09-26 S Sale
1.5
KCK LTD.
Large shareholder
5,821 -0.1%
6.62
US$38,535 		5,821 -0.1% 6.62 US$38,535
2024-10-03 2024-09-25 S Sale
1.5
KCK LTD.
Large shareholder
5,858 -0.1%
6.60
US$38,663 		5,858 -0.1% 6.60 US$38,663
2024-10-03 2024-09-23 S Sale
1.5
KCK LTD.
Large shareholder
282 -0.0%
7.54
US$2,126 		282 -0.0% 7.54 US$2,126
2024-10-03 2024-09-20 S Sale
1.5
KCK LTD.
Large shareholder
765 -0.0%
7.50
US$5,738 		765 -0.0% 7.50 US$5,738
2024-10-03 2024-09-13 S Sale
1.5
KCK LTD.
Large shareholder
1,993 -0.0%
7.59
US$15,127 		1,993 -0.0% 7.59 US$15,127
2024-10-03 2024-09-06 S Sale
1.5
KCK LTD.
Large shareholder
11 -0.0%
7.50
US$82 		11 -0.0% 7.50 US$82
2024-10-03 2024-09-04 S Sale
1.5
KCK LTD.
Large shareholder
14 -0.0%
7.50
US$105 		14 -0.0% 7.50 US$105
2024-10-03 2024-09-03 S Sale
1.5
KCK LTD.
Large shareholder
2,093 -0.0%
7.60
US$15,907 		2,093 -0.0% 7.60 US$15,907
2024-10-03 2024-08-30 PrS Proposed sale
1.5
KCK LTD.

10% Stockholder

Large shareholder
190,000
7.76
US$1,474,400 		190,000 7.76 US$1,474,400
2024-10-03 2024-08-30 S Sale
1.5
KCK LTD.
Large shareholder
4,314 -0.1%
7.76
US$33,477 		4,314 -0.1% 7.76 US$33,477
2024-05-03 2024-05-03 S Sale
2.6
ORBIMED ADVISORS LLC
Large shareholder
4,674 -0.1%
14.03
US$65,576 		4,674 -0.1% 14.03 US$65,576
2024-05-03 2024-05-02 S Sale
2.6
ORBIMED ADVISORS LLC
Large shareholder
8,842 -0.3%
14.01
US$123,876 		8,842 -0.3% 14.01 US$123,876
2024-05-03 2024-05-01 S Sale
2.6
ORBIMED ADVISORS LLC
Large shareholder
15,690 -0.5%
14.02
US$219,974 		15,690 -0.5% 14.02 US$219,974
2024-04-26 2024-04-24 S Sale
2.6
ORBIMED ADVISORS LLC
Large shareholder
1,781 -0.1%
14.06
US$25,041 		1,781 -0.1% 14.06 US$25,041
2024-04-23 2024-04-23 S Sale
2.6
ORBIMED ADVISORS LLC
Large shareholder
21,791 -0.6%
14.29
US$311,393 		21,791 -0.6% 14.29 US$311,393
2024-04-23 2024-04-22 S Sale
2.6
ORBIMED ADVISORS LLC
Large shareholder
24,609 -0.7%
14.05
US$345,756 		24,609 -0.7% 14.05 US$345,756
2024-04-23 2024-04-19 S Sale
2.6
ORBIMED ADVISORS LLC
Large shareholder
18,253 -0.5%
14.02
US$255,907 		18,253 -0.5% 14.02 US$255,907
2024-04-18 2024-04-18 S Sale
2.6
ORBIMED ADVISORS LLC
Large shareholder
2,623 -0.1%
14.06
US$36,879 		2,623 -0.1% 14.06 US$36,879
2024-04-18 2024-04-17 S Sale
2.6
ORBIMED ADVISORS LLC
Large shareholder
300 -0.0%
14.15
US$4,245 		300 -0.0% 14.15 US$4,245
2024-04-18 2024-04-16 S Sale
2.6
ORBIMED ADVISORS LLC
Large shareholder
14,069 -0.4%
14.01
US$197,107 		14,069 -0.4% 14.01 US$197,107
2024-04-15 2024-04-12 S Sale
2.6
ORBIMED ADVISORS LLC
Large shareholder
23,101 -0.7%
14.42
US$333,116 		23,101 -0.7% 14.42 US$333,116
2024-04-15 2024-04-11 S Sale
2.6
ORBIMED ADVISORS LLC
Large shareholder
461,899 -11.5%
14.49
US$6,692,917 		461,899 -11.5% 14.49 US$6,692,917
2024-03-15 2024-03-15 PrS Proposed sale
Irina Ridley

Chief Legal Officer

Officer
3,936
13.63
US$53,629 		3,936 13.63 US$53,629
2024-02-06 2024-02-05 PlS Planned sale
Morrell Martha

Chief Medical Officer

Officer
3,446 -4.2%
15.17
US$52,278 		3,446 -4.2% 15.17 US$52,278
2024-02-06 2024-02-02 PlS Planned sale
Morrell Martha

Chief Medical Officer

Officer
14,143 -14.8%
15.07
US$213,122 		14,143 -14.8% 15.07 US$213,122
2024-02-01 2024-02-01 PlS Planned sale
Morrell Martha

Chief Medical Officer

Officer
663 -0.7%
15.04
US$9,971 		663 -0.7% 15.04 US$9,971
2024-02-01 2024-01-31 PlS Planned sale
Morrell Martha

Chief Medical Officer

Officer
1,923 -2.0%
15.08
US$28,990 		1,923 -2.0% 15.08 US$28,990
2024-02-01 2024-01-30 PlS Planned sale
Morrell Martha

Chief Medical Officer

Officer
11,262 -10.3%
15.10
US$170,004 		11,262 -10.3% 15.10 US$170,004
2024-01-26 2024-01-25 PlS Planned sale
Morrell Martha

Chief Medical Officer

Officer
1 -0.0%
15.00
US$15 		1 -0.0% 15.00 US$15
2024-01-26 2024-01-24 PlS Planned sale
Morrell Martha

Chief Medical Officer

Officer
827 -0.8%
15.03
US$12,426 		827 -0.8% 15.03 US$12,426
2023-12-28 2023-12-27 PlS Planned sale
Morrell Martha

Chief Medical Officer

Officer
13,300 -10.8%
10.12
US$134,648 		13,300 -10.8% 10.12 US$134,648
2023-12-28 2023-12-26 PlS Planned sale
Morrell Martha

Chief Medical Officer

Officer
102 -0.1%
10.00
US$1,020 		102 -0.1% 10.00 US$1,020
2023-12-22 2023-12-20 PlS Planned sale
Morrell Martha

Chief Medical Officer

Officer
2,730 -2.2%
10.14
US$27,695 		2,730 -2.2% 10.14 US$27,695
2023-12-20 2023-12-20 PrS Proposed sale
Martha Morrell

Chief Medical Officer

Officer
48,397
9.99
US$483,486 		48,397 9.99 US$483,486
2023-12-07 2023-12-06 PlS Planned sale
Morrell Martha

Chief Medical Officer

Officer
11,005 -8.0%
8.16
US$89,773 		11,005 -8.0% 8.16 US$89,773
2023-12-06 2023-12-06 PrS Proposed sale
Martha Morrell

Affiliate
11,005
8.16
US$89,773 		11,005 8.16 US$89,773
2023-12-01 2023-12-01 S Sale
1.5
KCK LTD.
Large shareholder
3,241 -0.1%
8.73
US$28,294 		3,241 -0.1% 8.73 US$28,294
2023-12-01 2023-11-30 S Sale
1.5
KCK LTD.
Large shareholder
7,282 -0.1%
8.84
US$64,373 		7,282 -0.1% 8.84 US$64,373
2023-12-01 2023-11-29 S Sale
1.5
KCK LTD.
Large shareholder
5,644 -0.1%
8.72
US$49,216 		5,644 -0.1% 8.72 US$49,216
2023-11-29 2023-11-28 S Sale
1.5
KCK LTD.
Large shareholder
4,681 -0.1%
8.75
US$40,959 		4,681 -0.1% 8.75 US$40,959
2023-11-29 2023-11-27 PrS Proposed sale
1.5
KCK Ltd.

Shareholder
262,836
8.74
US$2,297,187 		262,836 8.74 US$2,297,187
2023-11-29 2023-11-27 S Sale
1.5
KCK LTD.
Large shareholder
6,490 -0.1%
8.96
US$58,150 		6,490 -0.1% 8.96 US$58,150
Explore more

More insider trading research around Neuropace Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America